Logo Logo
Switch Language to German
Kuendgen, A.; Lauseker, Michael; List, A. F.; Fenaux, P.; Giagounidis, A. A.; Brandenburg, N. A.; Backstrom, J.; Glasmacher, A.; Hasford, Joerg; Germing, U. (2013): Lenalidomide does not increase AML progression risk in RBC transfusion-dependent patients with Low- or Intermediate-1-risk MDS with del(5q): a comparative analysis. In: Leukemia, Vol. 27, No. 5: pp. 1072-1079
Full text not available from 'Open Access LMU'.